Listen Labs Walks Away From Signed $1.5B Term Sheet as Salesforce Talks Heat Up

Listen Labs, an AI research startup, pulled out of a signed Series C term sheet that would have valued the company at roughly $1.5 billion, according to sources familiar with the situation. Menlo Ventures had already committed to the round, and the paperwork was signed before the company reversed course. The about-face came as acquisition talks with Salesforce gained momentum, the sources said.

The sequence matters because a signed term sheet is normally the point at which a financing stops being competitive. Walking away from one is rare, and it signals that something larger than a venture round is on the table. In this case, that something is a potential sale to Salesforce, which has been assembling AI research talent and tooling through both acquisitions and internal hiring over the past two years.

Menlo Ventures has been one of the more active backers of applied AI companies, and a $1.5 billion mark for Listen Labs would have been a notable step up in valuation for a research-focused startup. The firm did not respond to a request for comment by publication time, and the terms of the term sheet have not been disclosed. Salesforces's interest, meanwhile, points to a buyer looking at research capability rather than a shipped product line.

For Listen Labs, the calculus is fairly simple on paper: a venture round delivers capital and independence, while an acquisition delivers a payout and a parent company's distribution. Founders in this position often weigh whether the next stage of the work needs a large sales organization, compute budget, or enterprise customer base that a strategic buyer already owns. The decision to abandon a signed deal suggests the Salesforce track is being treated as the primary path, not a fallback.

Nothing is finalized. Acquisition talks can stall over price, retention packages for researchers, or how the team would sit inside Salesforce's existing AI organization. Watch for whether Menlo Ventures re-engages, whether another strategic buyer enters, and whether Listen Labs discloses anything about its funding status in the coming weeks. The open question is whether a signed term sheet can be revived if the Salesforce discussions fall apart — or whether the startup has already closed that door.

The episode also says something about the current market for AI research teams. Buyers are moving early, sometimes before a company has a commercial product, and that pressure is reshaping how founders sequence fundraising against strategic interest. Listen Labs is now the clearest recent example of a startup choosing the strategic route over the venture one.